Navigation Links
PRI Condemns PEPFAR Amendments
Date:2/6/2008

FRONT ROYAL, Va., Feb. 6 /PRNewswire-USNewswire/ --- Population Research Institute has joined other pro-life groups in condemning amendments to the President's Emergency Plan for AIDS Relief (PEPFAR).

PEPFAR is up for reauthorization on Thursday, February 14, 2008, in the House Foreign Affairs Committee. According to PRI's president Steven Mosher, the preliminary drafts have been compromised by amendments that put the money directly in the hands of known population controllers.

"It would be better if President Bush had never proposed PEPFAR, than to have 50 billion dollars hijacked by abortion-promoting, chastity-mocking, anti-people groups like IPPF, UNFPA, and the Chinese government," said Mosher. "If the amendments promoted by the Democrat majority are passed, a veto will be the President's only option."

These amendments include "family planning" language that does not exclude abortion, lifting important abortion restrictions imposed by the Mexico City Policy, a removal of the anti-prostitution pledge, and a full integration of family planning services with HIV aid services.

PRI urges pro-lifers everywhere to contact the members of the House Foreign Affairs Committee and encourage them to vote against this bill. Information about this committee can be found at http://www.foreignaffairs.house.gov.

The Population Research Institute (PRI) was founded in 1989 by Fr. Paul Marx, OSB, PhD and is dedicated to: (1) ending human rights abuses committed in the name of "family planning," (2) opposing outdated social and economic paradigms premised on the myth of overpopulation, (3) informing the public about the social and economic benefits of moderate population growth, and (4) promoting pro-natal and pro-family attitudes and policies worldwide.


'/>"/>
SOURCE Population Research Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Catholic Health Association Condemns Denial of Health Insurance for Children
2. Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
3. China Sky One Medical Completes Previously Announced Amendments to Form 10QSB for the Second and Third Quarters of 2006
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... ... February 18, 2017 , ... ... the latest information and contact points to easily connect elderly veterans of America's ... living, and elder-care funding. It also conveys material on this year's increase in ...
(Date:2/17/2017)... ... 2017 , ... While EHR data has revolutionized the nursing ... workstation designed to reduce nursing fatigue while enhancing productivity. Based on field experience ... lightweight, highly mobile, multi-functional alternative to the limitations of handheld computing. , Nurses ...
(Date:2/17/2017)... ... 17, 2017 , ... Wells Pharmacy Network offers physicians WellsPx3, ... and non-controlled substances plus the ability to manage orders on their desktop or ... accept electronic prescriptions, according to the Office of the National Coordinator of Health ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... Webinar**, Feb. 22, 2017 — 1:30 p.m. – 2:30 p.m. ET, ... be asking before selecting an FDA approval pathway? , How should they ...
(Date:2/17/2017)... ... 17, 2017 , ... Corrective Action & Preventive Action for ... Feb. 23, 2017 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/capamd      ... action (PA)? , The methods share techniques and tools but they are different ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... NEW YORK , Feb. 17, 2017 /PRNewswire/ ... announced today the partnership of their 3D body ... in healthcare IT.  The new integration will be ... on an interactive model of the human body. ... data saves clinicians time, while also increasing the ...
(Date:2/16/2017)... Feb. 16, 2017 Research and Markets ... Emerging Medical Device Technologies" report to their offering. ... Traditional ... procedures, general instruments, non-drug coated implantables, large endoscopes, needle based ... use over the last two to three decades for the ...
(Date:2/16/2017)... 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ... announced that executive management will participate in the RBC ... 22-23, 2017. Adrian Adams , Chief Executive Officer, ... p.m. local time on Wednesday, February 22, 2017. ... event may be accessed from the Investors section of ...
Breaking Medicine Technology: